expert insights webinars

Award-winning experts share their detailed and actionable insights to inform the future of pharma, biotech, and medical devices

View the our complimentary webinar offerings below and register for one or more webinars.

Expert Insights webinars, presented by MMS

The Expert Insights webinar series offers free learning opportunities on current trends, high-value topics, and complex initiatives in the evolving pharmaceutical, biotechnology, and medical device industries. Current and archived webinars are available as follows:


Best Practices for Data Visualization in Pharma (July 15)
Date: July 15, 2020 at 2:00pm ET (11:00am PT)

Abstract: This Expert Insights webinar will focus on best practices for data visualization in the pharmaceutical industry. Data practitioners and consumers are increasingly dissatisfied with static and out-of-date views of their data. There is an increasing need in the pharmaceutical industry for interactive visualization tools and analytical strategies to gain better data insights using near-real-time data. This is particularly true in the current era where advanced technologies are producing Real World Data (RWD) at an astronomical pace and these data are becoming more commonly used. The ability to quickly gain insights from data used to be an advantage, but now it is a requirement.

Attendees will learn:

  • Industry best practices for developing practical data visualizations,
  • Tips on identifying and avoiding common pitfalls,
  • The development process for interactive dashboards from initial discovery through User Acceptance Testing (UAT) and validation strategies, and
  • The importance of understanding the intended audience and planned use for data visualizations.

A sample interactive COVID-19 dashboard focused on simulations of COVID-19 test reliability and performance will be presented through the MMS proprietary Datacise platform – a highly-scalable system utilizing state of the art tools and methodologies to perform data visualization and analyses of a myriad of data sources, including RWD.


Eric Harvey, PhD, Director, Biostatistics and Data Science at MMS

Christopher Hurley, Associate Director, Data Sciences at MMS, and PHUSE Americas Director

Benefit-Risk Assessments for Marketing Applications: Employing a Well-Structured and Thorough Approach (August 5)
Date: August 5, 2020, 2:00 pm ET (11:00 am PT)

Abstract: This Expert Insights webinar will focus on the format and structure of the benefit-risk information and discuss differences in approach when preparing this section of the clinical overview for FDA or EMA review, along with considerations for preparation of global dossiers. Employing the strategies discussed will have the potential to result in a better experience for key stakeholders, as well as improved quality of this important component of an ICH-compliant marketing application.

Attendees will learn:

  • How and when to begin the risk assessment,
  • Strategic approaches to content development,
  • Common misconceptions regarding content to be included in this section, and
  • Techniques for directing team efforts.


Amanda Beaster, PhD, Senior Technical Manager, Regulatory & Medical Writing

Erin Booth, PhD, Manager, Regulatory and Medical Writing

Ensuring Success in Implementing EMA Policy 0070 and Health Canada PRCI (August 20)
This Expert Insights webinar will focus on key transparency strategies in implementing European Medicines Agency (EMA) Policy 0070 and Health Canada Public Release of Clinical Information (PRCI) requirements for the publication of clinical trial data. Approaches, strategies, and challenges for both health authority requirements will be discussed at-length. Additionally, a conversation surrounding technology will focus on processes and technology to help facilitate implementation, including risks, benefits, and how to scale. A live question and answer session will conclude this complimentary webinar.

Attendees will learn:

  • Strategies and challenges in implementing EMA Policy 0070 and Health Canada PRCI,
  • Approaches to ensuring success in data sharing,
  • Processes and technologies to facilitate implementation,
  • Risks and/or benefits of choosing an approach/technology, and
  • How to build documents for different sharing requirements.


Kelly Vaillant, Director, Global Transparency Strategy & Compliance

Register for a webinar


2 + 7 =

Data Management
& Biostatistics

& Medical Writing

Drug Safety
& Pharmacovigilance

& Transparency



6880 Commerce Blvd.
Canton, MI 48187 USA
734.245.0310 T
734.245.0320 F

Email Us




Learn more about working with MMS

15 + 13 =

© MMS Holdings Inc. All rights reserved. Privacy Policy